CLARITY: Clinical Efficacy and Mechanistic Evaluation of Aflibercept for Proliferative Diabetic Retinopathy.

New funded trial by UMS member: Professor Toby Prevost

2014-2017  CLARITY: Clinical Efficacy and Mechanistic Evaluation of Aflibercept for Proliferative Diabetic Retinopathy.

PI: S.Sivaprasad (KCH and Moorfields). NIHR EME 12_66_15 £1.2M. (36 months).

http://www.nets.nihr.ac.uk/projects/eme/126615

Advertisements